These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 37193244)

  • 1. Severity of SARS-CoV-2 reinfection in vaccinated healthcare workers.
    Golshahi F; Siami Z; Feizabad E; Rajabzadeh S; Zarinjooie S; Albaji M; Mabadi A; Azarnoush A; Nazemi P
    Iran J Microbiol; 2023 Apr; 15(2):196-200. PubMed ID: 37193244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary SARS-CoV-2 Infections, Re-infections and Vaccine Effectiveness during the Omicron Transmission Period in Healthcare Workers of Trieste and Gorizia (Northeast Italy), 1 December 2021-31 May 2022.
    Cegolon L; Negro C; Mastrangelo G; Filon FL;
    Viruses; 2022 Nov; 14(12):. PubMed ID: 36560692
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antibody Response After Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthcare Workers with and without Previous COVID-19 Infection: A Prospective Observational Study].
    Özgür D; Tütüncü EE
    Mikrobiyol Bul; 2022 Jan; 56(1):36-48. PubMed ID: 35088958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The Second Shot of CoronaVac Vaccine May Cause Reduction of Antibody Levels in People who Previously had COVID-19].
    Topkaya AE; Keskin AÜ; Dalan AB; Çıragil P
    Mikrobiyol Bul; 2022 Jan; 56(1):139-142. PubMed ID: 35088968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of BNT162b2 mRNA Coronavirus Disease 2019 (COVID-19) Vaccine Against Acquisition of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Healthcare Workers in Long-Term Care Facilities: A Prospective Cohort Study.
    Muhsen K; Maimon N; Mizrahi A; Bodenheimer O; Cohen D; Maimon M; Grotto I; Dagan R
    Clin Infect Dis; 2022 Aug; 75(1):e755-e763. PubMed ID: 34698808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics of healthcare workers with SARS-CoV-2 infection after vaccination with BNT162b2 vaccine.
    Lombardi A; Renisi G; Consonni D; Oggioni M; Bono P; Uceda Renteria S; Piatti A; Pesatori AC; Castaldi S; Muscatello A; Riboldi L; Ceriotti F; Gori A; Bandera A
    BMC Infect Dis; 2022 Jan; 22(1):97. PubMed ID: 35090388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delay between COVID-19 complete vaccination and SARS-CoV-2 infection among healthcare workers.
    Saade A; Cha L; Tadié E; Jurado B; Le Bihan A; Baron-Latouche P; Febreau C; Thibault V; Garlantezec R; Tattevin P; Paris C
    Vaccine; 2022 May; 40(23):3159-3164. PubMed ID: 35465980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmission of SARS-CoV-2 variant B.1.1.7 among vaccinated health care workers.
    Ioannou P; Karakonstantis S; Astrinaki E; Saplamidou S; Vitsaxaki E; Hamilos G; Sourvinos G; Kofteridis DP
    Infect Dis (Lond); 2021 Nov; 53(11):876-879. PubMed ID: 34176397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections.
    Desmecht S; Tashkeev A; El Moussaoui M; Marechal N; Perée H; Tokunaga Y; Fombellida-Lopez C; Polese B; Legrand C; Wéry M; Mni M; Fouillien N; Toussaint F; Gillet L; Bureau F; Lutteri L; Hayette MP; Moutschen M; Meuris C; Vermeersch P; Desmecht D; Rahmouni S; Darcis G
    Front Immunol; 2022; 13():863554. PubMed ID: 35711445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Willingness to receive SARS-CoV-2 vaccine among healthcare workers in public institutions of Zhejiang Province, China.
    Wang J; Feng Y; Hou Z; Lu Y; Chen H; Ouyang L; Wang N; Fu H; Wang S; Kan X; Liao Y; Lu G; Mao J; Lin J; Wu M
    Hum Vaccin Immunother; 2021 Sep; 17(9):2926-2933. PubMed ID: 33848217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-vaccination SARS-CoV-2 infection among healthcare workers in tertiary care hospitals in Saudi Arabia: A case series.
    Alshamrani MM; Farahat FM; El-Saed A; Alzunitan M; Alsaedi A; El Gammal A; Al Nasser W; Nazeer S; Almohrij SA
    J Infect Public Health; 2022 Jan; 15(1):10-12. PubMed ID: 34856434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-Reported adverse events among Chinese healthcare workers immunized with COVID-19 vaccines composed of inactivated SARS-CoV-2.
    Cheng Y; Li T; Zheng Y; Xu B; Bi Y; Hu Y; Zhou YH
    Hum Vaccin Immunother; 2022 Nov; 18(5):2064134. PubMed ID: 35452357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are SARS-CoV-2 Antibodies Detectable in Human Milk After Vaccination Against COVID-19?
    Scaggs Huang F
    J Pediatric Infect Dis Soc; 2022 Apr; 11(4):126. PubMed ID: 35394545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of two coronavirus disease 2019 (COVID-19) vaccines (viral vector and inactivated viral vaccine) against severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection in a cohort of healthcare workers.
    Marra AR; Miraglia JL; Malheiros DT; Guozhang Y; Teich VD; da Silva Victor E; Pinho JRR; Cypriano A; Vieira LW; Polonio M; Ornelas RH; de Oliveira SM; Borges Junior FA; Shibata ARO; Schettino GPP; de Oliveira KG; Ferraz Santana RA; de Mello Malta F; Amgarten D; Boechat AL; Trecenti NMZ; Kobayashi T; Salinas JL; Edmond MB; Rizzo LV
    Infect Control Hosp Epidemiol; 2023 Jan; 44(1):75-81. PubMed ID: 35351217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 vaccine breakthrough infection among fully vaccinated healthcare workers in Duhok governorate, Iraqi Kurdistan: A retrospective cohort study.
    Almufty HB; Mamani MMA; Ali AH; Merza MA
    J Med Virol; 2022 Nov; 94(11):5244-5250. PubMed ID: 35811398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demographic and risk characteristics of healthcare workers infected with SARS-CoV-2 from two tertiary care hospitals in the United Arab Emirates.
    Nasa P; Modi P; Setubal G; Puspha A; Upadhyay S; Talal SH
    World J Virol; 2023 Mar; 12(2):122-131. PubMed ID: 37033144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody response to the inactivated SARS-CoV-2 vaccine among healthcare workers, Indonesia.
    Cucunawangsih C; Wijaya RS; Lugito NPH; Suriapranata I
    Int J Infect Dis; 2021 Dec; 113():15-17. PubMed ID: 34614445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of an outbreak of symptomatic SARS-CoV-2 VOC 202012/01-lineage B.1.1.7 infection in healthcare workers, Italy.
    Loconsole D; Sallustio A; Accogli M; Leaci A; Sanguedolce A; Parisi A; Chironna M
    Clin Microbiol Infect; 2021 Aug; 27(8):1174.e1-1174.e4. PubMed ID: 33984489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of previous exposure to SARS-CoV-2 and of S-Trimer (SCB-2019) COVID-19 vaccination on the risk of reinfection: a randomised, double-blinded, placebo-controlled, phase 2 and 3 trial.
    Smolenov I; Han HH; Li P; Baccarini C; Verhoeven C; Rockhold F; Clemens SAC; Ambrosino D; Richmond P; Siber G; Liang J; Clemens R;
    Lancet Infect Dis; 2022 Jul; 22(7):990-1001. PubMed ID: 35447085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.